智通财经APP获悉,周三,Hims & Hers Health(HIMS.US)股价拉涨,截至发稿,该股涨超15%,报67.4美元。消息面上,该公司已成功收购一家家庭实验室检测机构。这一举措将大幅提升公司在远程医疗和个性化健康管理领域的能力,并最终为订阅用户提供经济实惠的全身健康检测服务。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.